pocketful logo light
pocketful logo light
Astec Lifesciences Ltd logo

Astec Lifesciences Ltd

NSE: ASTEC BSE: 533138

736.65

(1.98%)

Sat, 30 May 2026, 10:46 pm

Astec Lifesciences Share Price Live Chart

1 Day

(1.98%)

No Result Found

Summary

  • Market Cap

    1717.63

  • Net Profit

    -134.71

  • P/B

    5.64

  • Sector P/E

    28.89

  • P/E

    -9.82

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.86

  • Interest Cover (Industry)

    1.80

  • ROCE (Industry)

    7.01

  • RONW (Industry)

    3.01

  • ROE

    -44.60

  • ROCE

    -12.60

  • Debt/Equity

    1.74

  • EPS (TTM)

    0

  • Dividend Yield

    0

  • Book Value

    175.30

  • Interest Cover

    -2.84

Analysis

all

thumbs up icon

Pros

  • Astec LifeSciences's earnings growth is expected to exceed the low risk savings rate of 7.2%.
  • Astec LifeSciences's earnings are expected to exceed the low risk growth rate next year.
  • Performance (ROE) is expected to be above the current IN Chemicals industry average.
  • Astec LifeSciences's revenue growth is expected to exceed the India market average.
  • Astec LifeSciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
thumbs up icon

Cons

  • Astec LifeSciences is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
  • No need to calculate the sustainability of Astec LifeSciences's dividends as it is not paying a notable one for India.
  • Astec LifeSciences is not paying a notable dividend for India, therefore no need to check if the payments are stable.
  • Astec LifeSciences's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Astec LifeSciences's dividend is below the markets top 25% of dividend payers in India (3.08%).

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters71.9771.9772.4270.8770.87
FII0.020.040.000.020.25
DII3.343.174.014.264.34
Public24.6724.8223.5724.8424.54
Government00000

Read More

Technical Analysis

RSI

60.73

MACD

24.92

50 DMA

663.38

200 DMA

709.15

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1137.53901.83798.27666.13562.57430.43194.73
Fibonacci901.83811.80756.17666.13576.10520.47430.43
Camarilla759.52737.91716.31666.13673.09651.49629.88

Pivots Level: Classic

R3

+471.40

1137.53

R2

+235.70

901.83

R1

+132.13

798.27

666.13
666.13
Pivot Point
LTP: 770.95

S1

-103.57

562.57

S2

-235.70

430.43

S3

-471.40

194.73

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    745.23

  • 20-EMA

    725.75

  • 30-EMA

    710.05

  • 50-EMA

    689.55

  • 100-EMA

    679.93

  • 200-EMA

    711.74

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 Apr 2026board-meetingsAccounts
27 Apr 2026agm
30 Jan 2026board-meetingsQuarterly Results, Nine Months Results
29 Oct 2025board-meetingsQuarterly Results
30 Jun 2025rights1:7 Rights Issue of Equity Shares04 Jul 2025
04 Jun 2025rightsRight Issue of Equity Shares04 Jul 2025
23 Apr 2025agm
23 Jun 2024agmAnnual General Meeting24 Jul 2024
02 May 2024agm
21 Jun 2023dividendAnnual General Meeting/Dividend - Rs 1.50 Per Share22 Jul 2023

Read More

Peer Comparison

Astec Lifesciences Ltd logo

Astec Lifesciences Ltd

Sumitomo Chemical India Ltd logo

Sumitomo Chemical India Ltd

UPL Ltd logo

UPL Ltd

Dhanuka Agritech Ltd logo

Dhanuka Agritech Ltd

Sharda Cropchem Ltd logo

Sharda Cropchem Ltd

P I Industries Ltd logo

P I Industries Ltd

Read More

Astec Lifesciences Ltd About

Astec Lifesciences manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates.

Industry

Pesticides / Agrochemicals - Indian

Founded

1994

Headquarters

CEO

N B Godrej

Employees

Contact

Website icon

Website

http://www.godrejastec.com

Email icon

Email

ipo@godrejastec.com; astecinfo@godrejastec.com; as

Phone icon

Phone

91-22-25188010

Location icon

Location

GodrejOne 3rd Fl Pirojshanagar, Vikhroli (E) Eastern Exp Highw, Mumbai, Maharashtra, 400079

Read More

Astec Lifesciences Ltd Company History

YearHistory
2018
  • Astec Lifesciences Ltd Wins Indian Chemical Council (ICC) Award For Excellence In Management
  • Astec Lifesciences Ltd amalgamated with Godrej Agrovet Limited
2019
  • Astec Lifesciences Ltd was awarded ICC Award for Excellence in Human Resource Management
2020
  • Astec Lifesciences Ltd is stake entire equity in Astec Europe Sprl
2021
  • Astec LifeSciences Limited commenced commercial production at its new Herbicide plant at Mahad
2023
  • Astec LifeSciences launches Rs. 100 crore Adi Godrej Center for Chemical Research and Development.
  • Astec LifeSciences launches R&D Center to develop new crop protection formulations.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell121381765.4118 May 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy121381765.0118 May 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell184770644.4710 Apr 2026
MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDbulkSell105543671.9910 Apr 2026
MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDbulkBuy130532661.5910 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy184770644.1210 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell220260600.1625 Mar 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy220551599.5425 Mar 2026
MATHISYS ADVISORS LLPbulkSell119613732.4209 Dec 2025
HRTI PRIVATE LIMITEDbulkBuy155505737.5609 Dec 2025

Read More

Astec Lifesciences Ltd News

Astec LifeSciences Grants 1,142 Stock Options Under ESOP

Astec LifeSciences Limited's Nomination and Remuneration Committee approved the grant of 1,142 stock options to an eligible employee under ESOP 2012 at Rs.10/- per option with 3-year vesting period.

30 Apr 2026

companies

Astec LifeSciences Grants 1,142 Stock Options Under ESOP

Astec LifeSciences Limited's Nomination and Remuneration Committee approved the grant of 1,142 stock options to an eligible employee under ESOP 2012 at Rs.10/- per option with 3-year vesting period.

30 Apr 2026

companies

Astec LifeSciences FY26 Results Show Revenue Growth

Astec LifeSciences reported total income of ₹45,321.65 crore for FY26, up from ₹38,693.22 crore in FY25. The company posted a net loss of ₹8,087.62 crore for the year ended March 31, 2026.

28 Apr 2026

companies

ASTEC LifeSciences Board Restructures Leadership

ASTEC LifeSciences announces major board changes with Nadir Godrej retiring as Chairman, Vishal Sharma appointed as new Chairman, and Burjis N. Godrej transitioning from Managing Director to Non-Executive Director.

13 Apr 2026

companies

ASTEC LifeSciences Board Restructures Leadership

ASTEC LifeSciences announces major board changes with Nadir Godrej retiring as Chairman, Vishal Sharma appointed as new Chairman, and Burjis N. Godrej transitioning from Managing Director to Non-Executive Director.

13 Apr 2026

companies

Read More